Background/Objectives: Variations in urinary symptom improvement after benign prostatic hyperplasia (BPH) surgery remain incompletely characterized. Preoperative factors, including bowel dysfunction, may influence postoperative recovery. We evaluated the association between baseline bowel function and urinary outcomes after holmium laser enucleation of the prostate (HoLEP), hypothesizing that worse baseline constipation would be associated with poorer outcomes. Methods: A prospective cohort study of patients undergoing HoLEP by a single surgeon at a high-volume center (December 2023–September 2024) was performed. Patients with neurogenic bladders, bowel disorders, or diabetes mellitus were excluded. Baseline bowel function was assessed using the Constipation Scoring System (CSS) and Vaizey Incontinence Score (VIS). The primary outcomes were 3-month changes in International Prostate Symptom Score (IPSS) and Michigan Incontinence Severity Index (MISI). Associations were evaluated using Spearman correlation and multivariable linear regression. Results: Among 102 patients (median age of 71.6 years), 81 (79.4%) completed follow-up. The median prostate size was 90.5 cc, and 50% had prior urinary retention. The baseline CSS and VIS were low. IPSS, quality of life, and MISI bother improved postoperatively, while MISI severity showed minimal change. Higher CSS correlated with higher VIS (p < 0.001). Baseline CSS and VIS were not associated with changes in IPSS, quality-of-life (QoL), or MISI bother. Baseline VIS was associated with modest improvement in MISI severity (β −1.14, p = 0.01). Conclusions: Baseline bowel function was not associated with urinary symptom improvement after HoLEP. However, preoperative fecal incontinence was associated with improvement in urinary incontinence severity.
Introduction: Studies validating the optimal high-power laser energy settings for holmium laser enucleation of the prostate (HoLEP) are lacking. The goal of our study is to determine if different laser settings during HoLEP influence operative time primarily and postoperative symptoms and complications secondarily. Methods: From March 2024 to April 2025, patients undergoing HoLEP with prostate measurements <200 mL were randomized 1:1:1 to laser energy settings of 2 Joules and 40, 50, or 60 Hertz (Hz) (NCT06531473). A high-power 120-watt holmium laser with pulse modulation was used for all patients. Patients were followed for 3 months postoperatively with daily surveys until day 14, surveys every third day until day 30, and then monthly thereafter until day 90. Postoperative outcomes were manually charted. Results: Out of 341 patients screened, 319 consented for the study, and 76 (23.8%) did not complete their daily surveys. There were no significant differences in baseline characteristics. Surgery duration was similar in all groups, but energy usage was significantly higher with increased frequency settings ( p < 0.001). Laser settings were changed from 40 Hz to 60 Hz in five cases and from 50 Hz to 60 Hz in one case due to inadequate coagulation effect. Patient-reported time to resolution of dysuria, difficult urination, incontinence, hematuria, and resumption of normal activity did not differ between cohorts ( p > 0.05). There were no differences in emergency room visits related to HoLEP ( p = 0.8). There was no difference in the change of IPSS or Michigan Incontinence Symptom Index scores between groups. Conclusion: Overall, there is no significant difference in the operative times and postoperative complications with the 2 J 40 Hz, 2 J 50 Hz, and 2 J 60 Hz laser settings for HoLEP, affirming the broad safety and efficacy of the procedure across diverse energy configurations.